findmyKOL
Clinical trialNCT00000949CompletedPhase 3Interventional

A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment460HIV Infections
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Community Consortium / Ucsf

    San Francisco, California, United States

  • Denver Cpcra / Denver Public Hlth

    Denver, Colorado, United States

  • Washington Reg Aids Prog / Dept of Infect Dis

    Washington D.C., District of Columbia, United States

  • Aids Research Consortium of Atlanta

    Atlanta, Georgia, United States

  • Aids Research Alliance - Chicago

    Chicago, Illinois, United States

  • Louisiana Comm Aids Rsch Prog / Tulane Univ Med

    New Orleans, Louisiana, United States

  • Henry Ford Hosp

    Detroit, Michigan, United States

  • Wayne State Univ - Wsu/dmc / Univ Hlth Ctr

    Detroit, Michigan, United States

  • Southern New Jersey Aids Clinical Trials

    Camden, New Jersey, United States

  • North Jersey Community Research Initiative

    Newark, New Jersey, United States

  • Partners in Research / New Mexico

    Albuquerque, New Mexico, United States

  • Harlem Aids Treatment Grp / Harlem Hosp Ctr

    New York, New York, United States

  • the Research and Education Group

    Portland, Oregon, United States

  • Philadelphia Fight

    Philadelphia, Pennsylvania, United States

  • Richmond Aids Consortium / Div of Infect Diseases

    Richmond, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
—
Primary completion
—
Completion
31 Jul 2000
Last update posted
29 Oct 2021
Registered enrollment
460
Registry id
NCT00000949
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.